Skip to main navigation Skip to search Skip to main content

20103: A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA IIIV) and left ventricular ejecti

Project: Research

Project Details

StatusFinished
Effective start/end date08/24/20 → 08/31/24

Funding

  • Bayer Healthcare Pharmaceuticals Incorporated: $19,530.00